Survival analysis

Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.

J. Zekri, Al-Shehri, A., Mahrous, M., Al-Rehaily, S., Darwish, T., Bassi, S., H Taani, E., A Zahrani, A., Elsamany, S., Al-Maghrabi, J., and Sadiq, B. B., “Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.”, Genet Mol Res, vol. 16, no. 1, 2017.

Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix

H. M. Zhang, Chen, S. Q., Yao, S. Z., Zhang, H. M., Chen, S. Q., and Yao, S. Z., “Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix”, vol. 15, p. -, 2016.

We investigated the expression and clinical implications of enhancer of Zeste homolog 2 (EZH2) and p53 protein in cervical squamous cell carcinoma (SCC) and precancerous lesions. EZH2 and p53 expressions in SCC (168), cervical intraepithelial neoplasia (CIN)-I (19), CIN-II (35), and normal tissues (30) were detected by streptavidin-peroxidase-conjugation. The correlation between co-expression of EZH2 and p53 protein and the clinic pathological features and prognosis of SCC were discussed.

Subscribe to Survival analysis